https://doi.org/10.1038/ng.3279
M
Max Jan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
5.4K
Citations
22
h-index
29
i10-index
Max Jan is an academic researcher from Massachusetts General Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Acute Myeloid Leukemia Research & Protein Degradation and Inhibitors. The author has an h-index of 22, co-authored 95 publications.
ORCID: 0000-0002-7071-5517Papers by this author
worksCOPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis
2015 · Nature Genetics · 389 citations
Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
2011 · Proceedings of the National Academy of Sciences · 303 citations
https://doi.org/10.1073/pnas.1100551108
Clonal hematopoiesis is associated with protection from Alzheimer’s disease
2023 · Nature Medicine · 135 citations
https://doi.org/10.1038/s41591-023-02397-2
Supplementary Figure S5 from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25728808
Supplementary Figure S3 from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25728820
Data from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7209145
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat